The Dialysafe trial aimed to reduce episodes of intradialytic hypotension during hemodialysis sessions at the clinic level.

Pulmonary hypertension risk increases with the severity of CKD, and affects up to two-thirds of patients receiving hemodialysis.

Cardiogenic shock is frequently complicated by acute kidney injury, so investigators set out to identify predictors.

Drug-induced acute kidney injury (AKI) frequently develops in hospitalized patients receiving nephrotoxic therapy.

Review authors suggested guidelines to help in standardizing future lupus nephritis studies. Heterogeneity in lupus nephritis (LN) trial design substantially hinders interpretation of studied drugs’ ...

Among hospitalized patients with septic shock, those with vs without low serum chloride levels or requirement for continuous renal replacement therapy (CRRT) have higher mortality ...

Researchers report results from a post hoc analysis evaluating the treatment response of sibeprenlimab vs placebo across different proteinuria thresholds in patients with IgA nephropathy.

The longitudinal assessment of albuminuria appears critical for assessing MACE risk in patients with and without CKD. The ...

Researchers report the impact of sparsentan vs irbesartan on proteinuria in patients with focal segmental glomerulosclerosis.

In the current study, investigators aimed to assess longitudinal trends in kidney disease-related deaths and temperature in the US. They analyzed data from the 2010-2020 US Centers for Disease Control ...

Investigators examined the prevalence of aluminum-containing medication exposure among patients on hemodialysis with diagnoses potentially attributable to aluminum toxicity.

Depression is prevalent among patients with CKD including those on dialysis. How depressive symptoms may affect cardiac structure and function has been underexplored.